AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimigen-M 3mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ekard Life Sciences Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Glimigen-M 3mg/500mg Tablet

DiabetaComb 3mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood sugar. DiabetaComb 3mg/500mg tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and potentially serious complications such as kidney impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan, which includes dietary adjustments, physical activity, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimigen-M 3mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glimigen-M 3mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimigen-M 3mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimigen-M 3mg/500mg Tablet should be administered with a meal.

Common Side effects of Glimigen-M 3mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigen-M 3mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 3mg/500mg Glimigen-M tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Glimigen-M 3mg/500mg Tablet works:

Glimepiride and Metformin, combined as Glimigen-M 3mg/500mg tablets, offer a dual approach to blood sugar management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, acts in three ways: reducing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimigen-M 3mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimigen-M 3mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Consult your physician for advice.

Breast feedingBreast feedingUNSAFE

The combination medication Glimigen-M (3mg/500mg tablets) is contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimigen-M 3mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. For individuals with severe kidney disease, this medication is contraindicated. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, the use of Glimigen-M 3mg/500mg tablets requires careful consideration. Dosage modification may be necessary. Medical advice is recommended. In patients experiencing mild to moderate liver disease, initiation should be at a low dosage; however, it's contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimigen-M 3mg/500mg Tablet :

Should you forget a Glimigen-M 3mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimigen-M 3mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimigen-M 3mg/500mg Tablet

Store this medication in its original, tightly closed container, following the instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glimigen-M 3mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimigen-M 3mg/500mg Tablets and seek immediate medical attention.
Glimigen-M 3mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glimigen-M is not suitable for type 1 DM.
Glimigen-M 3mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glimigen-M 3mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimigen-M 3mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimigen-M 3mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimigen-M 3mg/500mg Tabl...
103
MRP 126
18% off